DERM US and EU Validation Study

NCT05126173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1111

Last updated 2023-06-28

No results posted yet for this study

Summary

This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.

Conditions

Interventions

DEVICE

Deep Ensemble for the Recognition of Malignancy (DERM)

An AI-based diagnosis support tool

Sponsors & Collaborators

  • Skin Analytics Limited

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-08-19
Completion
2022-09-15
FDA Device
Yes

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126173 on ClinicalTrials.gov